Rhythm Pharmaceuticals, Inc. RYTM Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Rhythm Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s earnings yield?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported earnings yield of -3.4% in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s earnings yield changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s earnings yield increased by 32.2% year-over-year, from -5% to -3.4%.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s earnings yield?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s earnings yield has grown at a -21.0% compound annual growth rate (CAGR), from -9% to -2.8%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.